FSD Pharma (HUGE) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free HUGE Stock Alerts $0.35 +0.03 (+9.38%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 12:01 PM | investorplace.comHUGE Stock Earnings: FSD Pharma Reported Results for Q1 2024May 16, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzdMay 15, 2024 | americanbankingnews.comShort Interest in FSD Pharma Inc. (NASDAQ:HUGE) Declines By 10.5%April 29, 2024 | msn.comNeural Networks And AI's Rapid Progression Ignite A Multi-Trillion-Dollar Economic ShiftApril 29, 2024 | seekingalpha.comWall Street Breakfast: Self-Driving PushApril 29, 2024 | thestreet.comTesla shares soar as Elon Musk returns from China with FSD 'Game Changer'April 29, 2024 | msn.comApple, Amazon, Fed Rates Could Have a Devastating Effect on Stocks, Here’s Why. And 5 Other Things to Know Before Markets Open.April 23, 2024 | finance.yahoo.comUS to provide 'significant' new security assistance for Ukraine, Biden tells ZelenskiyApril 23, 2024 | news.yahoo.comI’m a doctor in Haiti. Crisis may be death sentence for many with health problems | OpinionApril 22, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzdApril 18, 2024 | msn.comSaudi Arabia Earns Top Marks in Global AI Index for National StrategyApril 18, 2024 | seekingalpha.comTesla Stock: Plunging Toward My Price TargetApril 17, 2024 | uk.investing.comFSD Pharma boosts loan to Celly Nutrition for new beverageApril 8, 2024 | msn.comTesla markets its FSD V12 with impressive real-world resultsMarch 29, 2024 | msn.comWalgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst saysMarch 28, 2024 | msn.comTesla stock slips as analysts issue a fresh round of warnings on Q1 deliveriesMarch 16, 2024 | benzinga.comPsychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News ReviewMarch 14, 2024 | msn.comMadrigal and liver drug developers fall ahead of FDA decision on NASH therapyMarch 11, 2024 | finance.yahoo.comFSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)March 7, 2024 | investing.comFSD Pharma reports positive Phase-1 MS drug trial resultsMarch 5, 2024 | finance.yahoo.comFSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 ForumFebruary 17, 2024 | finance.yahoo.comHUGE Mar 2024 1.000 callFebruary 16, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Announces US ATM OfferingFebruary 16, 2024 | finance.yahoo.comFSD Pharma Announces US ATM OfferingFebruary 6, 2024 | msn.comBig Pharma Targets Smaller Companies With Megadeals Out of FavorFebruary 6, 2024 | finanznachrichten.deFSD Pharma Inc.: Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 MillionFebruary 6, 2024 | finance.yahoo.comCourt of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 MillionFebruary 3, 2024 | investing.comFSD Pharma Inc Class B (HUGE)February 2, 2024 | msn.comTwo women injured in northeast Memphis crashFebruary 2, 2024 | techcrunch.comPitch Deck Teardown: PhageLab’s $11M Series A deckJanuary 29, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate UpdatesJanuary 29, 2024 | finance.yahoo.comFSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate UpdatesJanuary 11, 2024 | finance.yahoo.comGBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss CaseDecember 22, 2023 | finance.yahoo.comFSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SECDecember 5, 2023 | finance.yahoo.comFSD Pharma Inc. Announces Closing of Private PlacementNovember 30, 2023 | finance.yahoo.comFSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of ArrangementNovember 21, 2023 | finance.yahoo.comFSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.November 17, 2023 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of ArrangementNovember 17, 2023 | finance.yahoo.comFSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of ArrangementNovember 15, 2023 | finance.yahoo.comFSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023November 6, 2023 | msn.comFSD Pharma files prelim base shelf prospectus to replace expired base shelf prospectusNovember 6, 2023 | finance.yahoo.comFSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf ProspectusOctober 23, 2023 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Files Management Information Circular for Proposed Arrangement with Celly NuOctober 5, 2023 | benzinga.comOntario Court Upholds Canadian Biopharmaceutical Win Over Former CEO In C$2.8M DisputeOctober 5, 2023 | finance.yahoo.comFSD Pharma and Celly Nu Enter Into Arrangement AgreementOctober 4, 2023 | finance.yahoo.comFSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of JusticeSeptember 22, 2023 | finance.yahoo.comInvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin HarringtonSeptember 13, 2023 | finance.yahoo.comFSD Pharma Announces Analyst Coverage Initiated by Singular ResearchAugust 25, 2023 | finance.yahoo.comFSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)August 2, 2023 | msn.comFSD Pharma signs licensing deal for alcohol detox drink Unbuzzd Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Gates is all about this tiny $2 stock (Ad)What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock… >>Click here to discover why Bill Gates is all about this tiny $2 stock. HUGE Media Mentions By Week HUGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUGE News Sentiment▼0.500.43▲Average Medical News Sentiment HUGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUGE Articles This Week▼41▲HUGE Articles Average Week Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Pieris Pharmaceuticals News Edesa Biotech News RedHill Biopharma News Purple Biotech News Kiora Pharmaceuticals News Tonix Pharmaceuticals News Eterna Therapeutics News Imunon News NeuroSense Therapeutics News Akari Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUGE) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
